BioSpace News Archive

Agilent's signage at its office in California

Agilent Pays $925M to Buy CDMO Biovectra to Boost Biologics, CRISPR Capabilities

The acquisition of the contract development and manufacturing organization will allow Agilent Technologies to provide a one-stop source for gene-editing services for its customers.

July 23, 2024

·

2 min read

·

Tristan Manalac

External view of the U.S. Securities and Exchange Commission in Washington, DC

Regulatory

SEC Hits Allarity With Wells Notice, Flags Alleged Violations in FDA Meeting

Allarity Therapeutics announced Monday that the Securities and Exchange Commission has made a preliminary determination recommending an enforcement action against the company for alleged violations of federal securities laws.

July 23, 2024

·

2 min read

·

Tristan Manalac

Merck Research Laboratories in South San Francisco, California

RSV

Merck Challenges AstraZeneca, Sanofi With Phase IIb/III Data for RSV Antibody

Merck’s clesrovimab lowered the risk of medically attended lower respiratory infections associated with RSV infection when used in infants, according to topline results announced Tuesday.

July 23, 2024

·

2 min read

·

Tristan Manalac

GSK's headquarters office building in Poznan, Poland

Drug Development

GSK’s Dovato Matches Efficacy of Gilead’s Biktarvy in Head-to-Head HIV Trial

In the largest study of its kind, GSK’s two-drug regimen Dovato demonstrated non-inferior efficacy compared to Gilead Sciences’ three-drug regimen Biktarvy for the treatment of HIV-1.

July 23, 2024

·

2 min read

·

Kate Goodwin

Entrance to the U.S. Department of Health and Human Services in Washington, DC

Gene therapy

HHS Issues Negative Opinion on Bluebird’s Fertility Support Program for Gene Therapies

The Department of Health and Human Services’ Office of the Inspector General found that bluebird bio’s fertility support program for its gene therapies could potentially violate federal anti-kickback statutes.

July 23, 2024

·

2 min read

·

Tristan Manalac